x

Coronavirus

Trudeau: Canada to Receive Up to 168,000 Doses of the Moderna COVID-19 Vaccine

December 15, 2020

TORONTO — Prime Minister Justin Trudeau says Canada is now contracted to receive up to 168,000 doses of the Moderna COVID-19 vaccine before the end of December, pending approval by Canada’s health regulator.

Trudeau says deliveries could begin within 48 hours of regulatory approval. Officials say they expect to approve use of the second vaccine soon.

Canadians have already started to receive vaccine shots developed by Pfizer and BioNTech. Trudeau says Canada expects to receive about 200,000 doses from Pfizer next week.

RELATED

LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Tornado Kills Multiple People in Iowa as Powerful Storms Again Tear Through Midwest

GREENFIELD, Iowa (AP) — Multiple people were killed when a tornado tore through a small town in Iowa and left a wide swath of obliterated homes and crumpled cars, while the howling winds also twisted and toppled wind turbines.

JAKARTA, Indonesia (AP) — Global nickel prices have soared since deadly violence erupted in the French Pacific territory of New Caledonia last week.

BANGKOK (AP) — Aviation investigators arrived in Bangkok Wednesday to learn how and why severe turbulence sent a Singapore Airlines plane into a sudden dive that tossed passengers and crew around the cabin, leaving a British man dead and dozens others injured.

ATHENS – Eirini Baroulaki, the oldest living woman in Greece, passed away at the age of 119 on May 14.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.